Stock Markets July 1, 2026 08:44 AM

FMC Agreement with Tessenderlo Injects $400M, Accelerates Debt Reduction Plan

Tessenderlo to acquire roughly 20% stake at $13.30 a share as FMC moves to meet its $1 billion debt paydown objective

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
FMC

FMC Corporation said Tessenderlo Group will buy about 20% of the company for roughly $400 million at $13.30 per share. The capital injection is intended to help FMC achieve its near-term debt reduction target and follows a strategic review initiated by the company earlier in the year. The deal is subject to customary closing conditions and regulatory approvals.

FMC Agreement with Tessenderlo Injects $400M, Accelerates Debt Reduction Plan
FMC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Tessenderlo Group will acquire approximately 20% of FMC’s outstanding common stock for about $400 million at $13.30 per share.
  • Proceeds from the investment are earmarked to help FMC achieve an approximately $1 billion debt paydown target and to preserve its independence.
  • The transaction concludes FMC’s strategic options review announced in February 2026 and is subject to customary conditions, including regulatory approvals; BofA Securities and Goldman Sachs are financial advisors to FMC.
  • Sectors affected include agricultural chemicals and corporate credit markets, given the impact on FMC’s balance sheet and recent financing activity.

FMC Corporation shares surged in premarket trading after the company disclosed that Belgium-based Tessenderlo Group will purchase roughly one-fifth of its outstanding common stock for about $400 million. The stake will be acquired at $13.30 per share, a transaction that FMC says will support its plan to reduce debt and preserve its independence.

The investment - representing approximately 20% of FMC’s common stock - directly supports the company’s stated goal of paying down about $1 billion of debt. FMC said the agreement concludes the strategic options review it launched in February 2026 and that proceeds from the Tessenderlo purchase will be used to lower leverage.

FMC's chairman, chief executive officer and president, Pierre Brondeau, described the board’s decision as the product of a "comprehensive and deliberate process," adding that the board is confident the agreement represents "the best path forward for our company and its shareholders."

Luc Tack, chief executive officer of Tessenderlo Group, said the investment fits the Belgian industrial group's approach of expanding its agricultural platform via minority positions in high-quality companies.

The transaction follows several recent capital and portfolio actions taken by FMC. In the months prior to the announcement, the company amended its Revolving Credit Facility, completed a secured high-yield bond offering that raised $1.2 billion, and reached an agreement to sell its India commercial business for $252 million. FMC also entered a strategic supply and license agreement with Corteva, Inc., which provides an initial prepayment of $200 million, and executed a framework agreement for a $114 million sale and leaseback related to its Newark, Delaware property.

FMC indicated the Tessenderlo transaction remains subject to customary closing conditions, including regulatory approvals. The company is working with BofA Securities and Goldman Sachs, which are serving as its financial advisors on the transaction.

Market reaction to the announcement was immediate: FMC shares climbed 8.3% in premarket trading on the news. Tessenderlo's investment and the accompanying capital moves are intended to put FMC on a clearer path to the debt paydown target it announced as part of its strategic review earlier this year.

This development completes a chapter of strategic review activity for FMC and shifts the company's near-term balance sheet focus toward deleveraging while continuing to operate as an independent business.

Risks

  • The transaction is subject to customary closing conditions and regulatory approvals, which could delay or prevent the deal from closing - relevant to investors and credit markets.
  • Execution risk around FMC’s broader restructuring and divestiture program, including the sale of its India commercial business and the implementation of the supply and license agreement with Corteva, which could affect expected cash flows.
  • Market and operational risk remain as FMC integrates the capital changes and manages debt reductions while maintaining independent operations - a potential concern for stakeholders in the agricultural chemicals sector.

More from Stock Markets

Hims & Hers Shares Rise After Canaccord Lifts Price Target to $40 Jul 1, 2026 Sony to Stop Producing PlayStation Game Discs in January 2028 Jul 1, 2026 Goldman Sachs Elevates Michael Bosworth to Acting General Counsel; Kathryn Ruemmler Steps Down Jul 1, 2026 Goldman: Draft U.S. Limits on Chinese Solar Inverters Would Reshape Commercial and Utility Markets More Than Residential Jul 1, 2026 Oxmiq Secures $35 Million to Create Integrated AI Chip Architecture and Software Jul 1, 2026